Clinical Trial Update: Head to Head, Prospective, Open Label Multicenter Study on the Diagnostic Efficacy of GPC3 Targeted PET Imaging and Enhanced Magnetic Resonance Imaging for Hepatocellular Carcinoma [EARLY_Phase 1]

View source ↗

Summary

This early-phase, multicenter trial is evaluating the diagnostic performance of a GPC3-targeted PET radiotracer in combination with enhanced MRI for hepatocellu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• GPC3-targeted PET imaging agent (Glypican-3 targeted radiotracer)

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Malignant Neoplasm of Liver | EARLY_Phase 1 | Status: NOT_YET_RECRUITING